Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial
Sign Up to like & getrecommendations! Published in 2023 at "Headache"
DOI: 10.1111/head.14439
Abstract: To assess long‐term safety, tolerability, and efficacy of once‐daily oral atogepant 60 mg in adults with migraine. read more here.
Keywords: atogepant long; long term; oral atogepant; daily oral ... See more keywords